The invention relates to substituted pyrrole compounds of Formula (I) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
本发明涉及一种式为(I)的取代
吡咯化合物,其可用作激酶
抑制剂,更具体地用作检查点激酶1(chk1)
抑制剂,因此可用作癌症治疗剂。本发明还涉及包含这些化合物的组合物,更具体地是包含这些化合物的制药组合物以及使用它们治疗各种癌症和增生性疾病的方法,以及使用这些化合物进行哺乳动物细胞的体外、体内诊断或治疗,或相关的病理条件的方法。